Investigation of the effects of YM-31636, a novel 5-HT3 receptor agonist, on defecation in normal and constipated ferrets

European Journal of Pharmacology
H ItoT Yamaguchi

Abstract

We examined the effects of YM-31636 (2-(1H-imidazol-4-ylmethyl)-8H-indeno[1,2-d]thiazole monofumarate), a newly synthesized 5-HT(3) receptor agonist, on defecation in normal and constipated ferrets, and evaluated it as an agent against constipation. YM-31636 facilitated defecation without inducing diarrhea or emetic episodes. This effect occurred within 1 h after oral administration, mostly within 30 min, whereas sodium picosulfate, a widely used laxative, tended to increase the frequency of defecation for several hours with much lower peak incidence than that of YM-31636, and induced diarrhea. UK14304 (brimonidine), an alpha2 receptor agonist, and morphine reduced the frequency of defecation and YM-31636 restored it. These effects of YM-31636 were antagonized by ramosetron, a 5-HT(3) receptor antagonist. These results suggest that YM-31636 could be promising in the treatment of constipation. Because of an early and reliable onset of action compared with sodium picosulfate, YM-31636 could make it easier to control the time of defecation.

References

Jan 17, 1991·European Journal of Pharmacology·L F SancilioH R Munson
Apr 1, 1990·Digestive Diseases and Sciences·N J TalleyA Ciociola
Jan 1, 1990·Digestive Diseases and Sciences·E H Livingston, E P Passaro
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·G M MaweM D Gershon
Mar 28, 1986·The American Journal of Cardiology·R E KeenanD L Wright
Aug 1, 1987·Journal of Clinical Gastroenterology·E CorazziariA Montesi
Feb 1, 1995·Seminars in Pediatric Surgery·V Loening-Baucke
Oct 1, 1994·Brain Research. Molecular Brain Research·P WernerK A Jones
Jun 1, 1994·Journal of the Autonomic Nervous System·J D Wood
Jul 20, 1993·European Journal of Pharmacology·T KamatoK Miyata
Jul 8, 2000·European Journal of Pharmacology·S MochizukiK Furuichi
Dec 6, 2000·European Journal of Pharmacology·H ItoT Yamaguchi
Jan 1, 1955·The American Journal of Nursing·I P FROHMAN

❮ Previous
Next ❯

Citations

Jul 11, 2002·Life Sciences·Yukinori NagakuraTokio Yamaguchi
Mar 30, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·H SudoH Takanashi
Oct 1, 2010·Experimental Biology and Medicine·Andreas Stengel, Yvette Taché

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.